Drawing for HAPPY BIRD

USPTO serial 98915126

HAPPY BIRD

Reviewed by CopyMark Law Group

Status 730Notice of Allowance
Filing date
Status date
Registration date
Examiner
CHHINA, KARANENDRA S
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 730: Status 730 means you filed the first six-month extension to delay filing a Statement of Use after a Notice of Allowance. You must file a Statement of Use or another extension before the new deadline.

Need help with HAPPY BIRD?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $249*

Plus Government fees of $150

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

William G. Heedy

William G. Heedy Coffield Heedy Kilgore PLLCPO Box 289ASHEVILLE, NC 28802United States

Goods and services

ClassDescriptionStatusFirst use
032Seltzer water; Flavored seltzer water; all of the foregoing cannabis related goods containing cannabis ingredients solely derived from hemp with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis, and not containing CBDACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 3, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 3, 2026EX1GSOU EXTENSION 1 GRANTED
Apr 2, 2026EXT1SOU EXTENSION 1 FILED
Apr 2, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 7, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 12, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 12, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 6, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 23, 2025LOPRLETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
Jul 23, 2025LOPRLETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
Apr 17, 2025LOPTLETTER OF PROTEST EVIDENCE FORWARDED
Apr 16, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 21, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Mar 21, 2025XAECEXAMINER'S AMENDMENT ENTERED
Mar 21, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 21, 2025GNEAEXAMINERS AMENDMENT E-MAILED
Mar 21, 2025CNEAEXAMINERS AMENDMENT -WRITTEN
Mar 19, 2025DOCKASSIGNED TO EXAMINER
Mar 15, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 15, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 15, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 20, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 20, 2024NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance